share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Sachdev Amit

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Sachdev Amit

福泰制药 | 4：持股变动声明-高管 Sachdev Amit
美股SEC公告 ·  06/07 16:14
Moomoo AI 已提取核心信息
Amit Sachdev, EVP Chief Patient & Ext Af Off at Vertex Pharmaceuticals Inc. (VRTX), completed a gift transaction of 4,600 shares of common stock on June 5, 2024. The shares were disposed of at no cost, as it was a bona fide gift. Following the transaction, Sachdev's direct holdings in the company remain at 57,290 shares. The shares disposed of were held in trust, indicating an indirect form of ownership. The transaction has been completed, and Sachdev now indirectly holds 882 shares after the event.
Amit Sachdev, EVP Chief Patient & Ext Af Off at Vertex Pharmaceuticals Inc. (VRTX), completed a gift transaction of 4,600 shares of common stock on June 5, 2024. The shares were disposed of at no cost, as it was a bona fide gift. Following the transaction, Sachdev's direct holdings in the company remain at 57,290 shares. The shares disposed of were held in trust, indicating an indirect form of ownership. The transaction has been completed, and Sachdev now indirectly holds 882 shares after the event.
2024年6月5日，维特克斯制药公司（VRTX）首席病患及外部事务执行副总裁Amit Sachdev完成了一项礼物交易，让出了4600股普通股，不收取费用，因为这是一个真正的礼物。交易后，Sachdev在公司的直接持股仍为57290股。出售的股份保留在信托中，表明这是一种间接形式的所有权。交易已经完成，Sachdev在此次事件之后间接持有882股。
2024年6月5日，维特克斯制药公司（VRTX）首席病患及外部事务执行副总裁Amit Sachdev完成了一项礼物交易，让出了4600股普通股，不收取费用，因为这是一个真正的礼物。交易后，Sachdev在公司的直接持股仍为57290股。出售的股份保留在信托中，表明这是一种间接形式的所有权。交易已经完成，Sachdev在此次事件之后间接持有882股。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息